Work on new UK value-based pricing system to start next April
This article was originally published in Scrip
As part of sweeping reform planned for the National Health Service in England, the UK coalition government is to begin developing a new value-based pricing strategy for drugs next April, and plans to create a new Cancer Drugs Fund in the same month. The reforms also involve an overhaul of the way in which healthcare services are commissioned.
You may also be interested in...
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
Patient access schemes have helped the Scottish Medicines Consortium recommend rare disease products, including Regeneron/Sanofi’s Libtayo for skin cancer.